Robert Dempster

Robert Dempster D.Phil
Principal

rob@maschiosoames.com

European Patent Attorney
Chartered UK Patent Attorney
University of Cambridge, M.Sc., Natural Sciences
University of Oxford, D.Phil, Pharmacology

Rob is a patent attorney specialising in biotechnology and pharmaceuticals. He has a particular interest in immunology, diagnostics, antibody technology, stem cells, molecular biology, bioinformatics, medical devices, food technology, gene therapy, drug delivery and formulation.

Rob has over fourteen years of professional experience in the field of intellectual property. He has gained much respect in the profession for his proven ability in advocacy in opposition and appeal proceedings. He is noted for his clear business focussed advice to clients ranging from academic institutions to multinational corporations on all aspects of patent law.

Rob attained a Masters in Natural Sciences from Cambridge University and his doctorate in Pharmacology from Oxford University. Prior to joining Maschio & Soames IP Ltd, he worked in large private practices in the UK and in the intellectual property department of Novartis.

Rob regularly presents to audiences worldwide on a variety of topics in patent law. He has a wealth of experience in organising seminars and webinars on European biotech patent practice, including in the fields of antibodies, stem cells and recent EPO case law.

Rob is married with two children and two rabbits. In his free time he enjoys competing in triathlons and running events, preferably somewhere mountainous.

Selected technical publications:

CXC chemokines generate age-related increases in neutrophil-mediated brain inflammation and blood-brain barrier breakdown. Current Biology (1998) 8(16):923-6.

Chemokine targets in acute brain injury and disease. Progress in Brain Research (2001) 132:507-24.